MedPath

Pharmaceutico analytical and clinical study of Herbo mineral compound along with Herbal formulation in the management of agni mandya (Thyroid disorder)

Phase 2
Conditions
Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism
Registration Number
CTRI/2023/09/057743
Lead Sponsor
ATIONAL INSTITUTE OF AYURVEDA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with subclinical hypothyroidism with TSH levels ranging from 5.5µIU/ml

- 15µIU/ml.

k/c/o subclinical hypothyroidism but still not taking Levothyroxine therapy.

Common symptoms subclinical hypothyroidism like fatigue, weight gain, dry skin, decreased appetite, oedema.

Exclusion Criteria

Patients suffering from congenital hypothyroidism, overt hypothyroidism, and secondary hypothyroidism.

Patients of hyperthyroidism, neoplasia, toxic goitre are excluded.

Patients who have undergone any type of thyroid surgery.

Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc.

Patients taking drugs known to alter thyroid hormone level (e.g., Amiodarone)

Recent hospitalization for major illness, to exclude with ESS (Euthyroid Sick Syndrome).

Patient having thyroxine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in TSH valueTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
change in general sign & symptoms associated with subclinical hypothyroidism. <br/ ><br>Reduction in Body weight & BMI <br/ ><br>Timepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath